| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
The Q3 earnings report for Mesa Laboratories (NASDAQ:MLAB) was released on Tuesday, February 4, 2025 at 08:00 AM.
Here's what investors need to know about the latest announcement.
Mesa Laboratories beat estimated earnings by 80.0%, reporting an EPS of $2.72 versus an estimate of $1.51.
Revenue was up $9.37 million from the same period last year.
Last quarter the company beat on EPS by $1.24 which was followed by a 1.0% increase in the share price the next day.
Here's a look at Mesa Laboratories's past performance:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | 1.38 | 0.44 | 2.33 | 0.19 |
| EPS Actual | 2.62 | 2.83 | 2.77 | 2.02 |
| Revenue Estimate | 57.88M | 55.74M | 55.27M | 54.89M |
| Revenue Actual | 57.83M | 58.17M | 58.90M | 53.47M |
To track all earnings releases for Mesa Laboratories visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: MLAB
